KDIGO Conversations in Nephrology features global experts covering a wide range of topics for clinicians treating patients with kidney disease.
KDIGO Conversations in Nephrology
Claim This Podcastby KDIGO Communications
4.8(9 reviews)
33 episodes
Updated Inactive
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
KDIGO Conversations in Nephrology features global experts covering a wide range of topics for clinicians treating patients with kidney disease.
Language
🇺🇲
Publishing Since
8/10/2021
2 verified contact emails on file for KDIGO Conversations in Nephrology
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 27, 2026
Episode 33: Treating FSGS: From Steroids to Dual Endothelin Angiotensin Receptor Antagonists and What Comes Next
<p>In the third episode of the <strong>KDIGO Conversations in Nephrology </strong>FSGS series, host <strong>Dr. Kirk Campbell</strong> (University of Pennsylvania) sits down with world-renowned glomerular disease expert Dr. Jai Radhakrishnan (Columbia University) to navigate the shifting landscape of Focal Segmental Glomerulosclerosis (FSGS) management.</p><p>The conversation dives deep into the diagnostic complexities of FSGS, moving beyond histological patterns to understand the diverse drivers of podocyte injury. Dr. Radhakrishnan shares his practical clinical algorithm, offering a roadmap for balancing supportive care, selective immunosuppression, and the integration of novel, non-immunosuppressive therapies. Join Drs. Campbell and Radhakrishnan as they discuss the robust pipeline of emerging agents in this field. </p><p><br></p>
May 27, 2026
Episode 32: Proteinuria First: Managing What Matters in FSGS
<p>In this second episode of the three-part KDIGO Conversations in Nephrology series, Dr. Kirk Campbell speaks with Dr. Laura Mariani about the central role of proteinuria reduction in the management of focal segmental glomerulosclerosis (FSGS). </p><p><br></p><p>The discussion explores the biologic link between podocyte injury and proteinuria, the goals and findings of the PARASOL initiative, and how proteinuria may help guide clinical trial design and treatment decisions in FSGS. Dr. Mariani also reflects on the importance of collaboration and data sharing in advancing therapies for rare glomerular diseases. </p>
May 27, 2026
Episode 31: The Podocyte Problem: Understanding FSGS
<p>Join Dr. Kirk Campbell (University of Pennsylvania) and Dr. Alessia Fornoni (University of Miami) for an in-depth conversation on the evolving landscape of Focal Segmental Glomerulosclerosis (FSGS). </p><p><br></p><p>The first episode of this three-part FSGS series explores the transition from traditional histological classifications to a more precise clinical and molecular understanding of the disease. Dr. Campbell and Dr. Fornoni discuss the definition and pathogenesis of FSGS as well as clinical management and the future of treatment. </p><p><br></p><p>In this episode of KDIGO Conversations in Nephrology, Dr. Kirk Campbell speaks with Dr. Alessia Fornoni about the evolving understanding of focal segmental glomerulosclerosis (FSGS) as a podocytopathy driven by podocyte injury. The discussion explores advances in FSGS classification, the role of angiotensin II and endothelin-1 signaling in disease progression, emerging insights into disease mechanisms, and how new targeted therapies may help preserve podocyte function and slow the progression of kidney disease. </p><p><br></p><p>This episode is part of a special three-part KDIGO Conversations in Nephrology series exploring advances in podocyte biology, disease mechanisms, emerging therapies, and the evolving clinical management of FSGS.</p>
33 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Clinical Journal of the American Society of Nephrology (CJASN)
American Society of Nephrology
GN in Ten
International Society of Glomerular Disease
Core IM | Internal Medicine Podcast
Core IM Team
The Clinical Problem Solvers
The Clinical Problem Solvers
JAMA Clinical Reviews
JAMA Network
Kidney360
American Society of Nephrology
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
NEJM This Week
NEJM Group
Harrison's PodClass: Internal Medicine Cases and Board Prep
AccessMedicine
The Curious Clinicians
The Curious Clinicians
White Coat Investor Podcast
Dr. Jim Dahle of the White Coat Investor
The #PDExchange Podcast
Peritoneal Dialysis International
Kidney Commute
kidneycommute
Freakonomics Radio
Freakonomics Radio + Stitcher
WSJ What’s News
The Wall Street Journal
Deep-dive analytics for KDIGO Conversations in Nephrology
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is KDIGO Conversations in Nephrology?
- How often does this podcast release new episodes?
This podcast updates inactive.
- Where can I listen to this podcast?
This podcast is available on 2 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.